Literature DB >> 32854531

Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI.

Clifford M Cassidy1, Kenneth M Carpenter1, Anna B Konova1, Victoria Cheung1, Alexander Grassetti1, Luigi Zecca1, Anissa Abi-Dargham1, Diana Martinez1, Guillermo Horga1.   

Abstract

OBJECTIVE: Recent evidence supports the use of neuromelanin-sensitive MRI (NM-MRI) as a novel tool to investigate dopamine function in the human brain. The authors investigated the NM-MRI signal in individuals with cocaine use disorder, compared with age- and sex-matched control subjects, based on previous imaging studies showing that this disorder is associated with blunted presynaptic striatal dopamine.
METHODS: NM-MRI and T1-weighted images were acquired from 20 participants with cocaine use disorder and 35 control subjects. Diagnostic group effects in NM-MRI signal were determined using a voxelwise analysis within the substantia nigra. A subset of 20 cocaine users and 17 control subjects also underwent functional MRI imaging using the monetary incentive delay task, in order to investigate whether NM-MRI signal was associated with alterations in reward processing.
RESULTS: Compared with control subjects, cocaine users showed significantly increased NM-MRI signal in ventrolateral regions of the substantia nigra (area under the receiver operating characteristic curve=0.83). Exploratory analyses did not find a significant correlation of NM-MRI signal to activation of the ventral striatum during anticipation of monetary reward.
CONCLUSIONS: Given that previous imaging studies show decreased dopamine signaling in the striatum, the finding of increased NM-MRI signal in the substantia nigra provides additional insight into the pathophysiology of cocaine use disorder. One interpretation is that cocaine use disorder is associated with a redistribution of dopamine between cytosolic and vesicular pools, leading to increased accumulation of neuromelanin. The study findings thus suggest that NM-MRI can serve as a practical imaging tool for interrogating the dopamine system in addiction.

Entities:  

Keywords:  Cocaine Use Disorder; Dopamine; Neuromelanin-Sensitive MRI; Substantia Nigra

Mesh:

Substances:

Year:  2020        PMID: 32854531      PMCID: PMC9108998          DOI: 10.1176/appi.ajp.2020.20010090

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   19.242


  40 in total

1.  Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates.

Authors:  Rajesh Narendran; Hank P Jedema; Brian J Lopresti; Neale Scott Mason; Michael L Himes; Charles W Bradberry
Journal:  Biol Psychiatry       Date:  2014-06-23       Impact factor: 13.382

2.  Affective traits link to reliable neural markers of incentive anticipation.

Authors:  Charlene C Wu; Gregory R Samanez-Larkin; Kiefer Katovich; Brian Knutson
Journal:  Neuroimage       Date:  2013-08-31       Impact factor: 6.556

3.  Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine.

Authors:  Diana Martinez; Rajesh Narendran; Richard W Foltin; Mark Slifstein; Dah-Ren Hwang; Allegra Broft; Yiyun Huang; Thomas B Cooper; Marian W Fischman; Herbert D Kleber; Marc Laruelle
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

4.  Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment.

Authors:  Diana Martinez; Kenneth M Carpenter; Fei Liu; Mark Slifstein; Allegra Broft; Alessandra Calvo Friedman; Dileep Kumar; Ronald Van Heertum; Herbert D Kleber; Edward Nunes
Journal:  Am J Psychiatry       Date:  2011-03-15       Impact factor: 18.112

5.  Decreasing striatal 6-FDOPA uptake with increasing duration of cocaine withdrawal.

Authors:  J C Wu; K Bell; A Najafi; C Widmark; D Keator; C Tang; E Klein; B G Bunney; J Fallon; W E Bunney
Journal:  Neuropsychopharmacology       Date:  1997-12       Impact factor: 7.853

6.  New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.

Authors:  Luigi Zecca; Chiara Bellei; Patrizia Costi; Alberto Albertini; Enrico Monzani; Luigi Casella; Mario Gallorini; Luigi Bergamaschi; Alberto Moscatelli; Nicholas J Turro; Melvin Eisner; Pier Raimondo Crippa; Shosuke Ito; Kazumasa Wakamatsu; William D Bush; Weslyn C Ward; John D Simon; Fabio A Zucca
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

7.  Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users.

Authors:  J M Wilson; A I Levey; C Bergeron; K Kalasinsky; L Ang; F Peretti; V I Adams; J Smialek; W R Anderson; K Shannak; J Deck; H B Niznik; S J Kish
Journal:  Ann Neurol       Date:  1996-09       Impact factor: 10.422

Review 8.  PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.

Authors:  Yoshitaka Kumakura; Paul Cumming
Journal:  Neuroscientist       Date:  2009-12       Impact factor: 7.519

9.  Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.

Authors:  Yoshiyuki Watanabe; Hisashi Tanaka; Akio Tsukabe; Yuki Kunitomi; Mitsuo Nishizawa; Ryota Hashimoto; Hidenaga Yamamori; Michiko Fujimoto; Masaki Fukunaga; Noriyuki Tomiyama
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

10.  Disruption of Reward Processing in Addiction : An Image-Based Meta-analysis of Functional Magnetic Resonance Imaging Studies.

Authors:  Maartje Luijten; Arnt F Schellekens; Simone Kühn; Marise W J Machielse; Guillaume Sescousse
Journal:  JAMA Psychiatry       Date:  2017-04-01       Impact factor: 21.596

View more
  8 in total

1.  Standardized Data Acquisition for Neuromelanin-sensitive Magnetic Resonance Imaging of the Substantia Nigra.

Authors:  Guillermo Horga; Kenneth Wengler; Garrett Salzman; Jocelyn Kim
Journal:  J Vis Exp       Date:  2021-09-08       Impact factor: 1.424

2.  Evidence for Dopamine Abnormalities Following Acute Methamphetamine Exposure Assessed by Neuromelanin-Sensitive Magnetic Resonance Imaging.

Authors:  Fei Tang; Hui Liu; Xiao Jie Zhang; Hui Hui Zheng; Yong Ming Dai; Li Yun Zheng; Wen Han Yang; Yan Yao Du; Jun Liu
Journal:  Front Aging Neurosci       Date:  2022-05-30       Impact factor: 5.702

3.  Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry.

Authors:  Guillermo Horga; Kenneth Wengler; Clifford M Cassidy
Journal:  JAMA Psychiatry       Date:  2021-07-01       Impact factor: 25.911

Review 4.  The chemical tools for imaging dopamine release.

Authors:  Michael R Post; David Sulzer
Journal:  Cell Chem Biol       Date:  2021-04-23       Impact factor: 9.039

5.  Cross-Scanner Harmonization of Neuromelanin-Sensitive MRI for Multisite Studies.

Authors:  Kenneth Wengler; Clifford Cassidy; Marieke van der Pluijm; Jodi J Weinstein; Anissa Abi-Dargham; Elsmarieke van de Giessen; Guillermo Horga
Journal:  J Magn Reson Imaging       Date:  2021-05-06       Impact factor: 5.119

Review 6.  Magnetic resonance imaging of the dopamine system in schizophrenia - A scoping review.

Authors:  Julia Schulz; Juliana Zimmermann; Christian Sorg; Aurore Menegaux; Felix Brandl
Journal:  Front Psychiatry       Date:  2022-09-20       Impact factor: 5.435

7.  High-Frequency Deep Brain Stimulation of the Substantia Nigra Pars Reticulata Facilitates Extinction and Prevents Reinstatement of Methamphetamine-Induced Conditioned Place Preference.

Authors:  Libo Zhang; Shiqiu Meng; Wenjun Chen; Yun Chen; Enze Huang; Guipeng Zhang; Yisen Liang; Zengbo Ding; Yanxue Xue; Yun Chen; Jie Shi; Yu Shi
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

8.  Substance Abuse in Emerging Adults: The Role of Neuromelanin and Ventral Striatal Response to Social and Monetary Rewards.

Authors:  Johanna M Jarcho; James B Wyngaarden; Camille R Johnston; Megan Quarmley; David V Smith; Clifford M Cassidy
Journal:  Brain Sci       Date:  2022-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.